Pfizer has launched Rimegepant ODT in India for adults who don’t respond to triptans. The fast-acting tablet offers up to ...

Rimegepant is an orally disintegrating tablet (ODT) - a class of medications called calcitonin gene-related peptide (CGRP) ...

Pfizer has launched Rimegepant ODT, a new migraine treatment in India. It offers rapid, lasting relief and targets patients ...

Rimegepant ODT is the new medication for migraine which can help adults with a previous insufficient response to triptan. Dr ...

New 75mg orally disintegrating tablet provides sustained, 48-hour pain relief without the risk of medication overuse ...

Pfizer has introduced Rimegepant ODT for adults who do not respond well to triptans, entering a migraine market nearing $200 ...

Pfizer launches Rimegepant ODT in India, offering rapid migraine relief for adults unresponsive to traditional treatments.

PRASHO and Pfizer launch migraine awareness and workplace productivity workshops in Hyderabad, addressing India’s major ...

Pfizer launches Rimegepant, a novel ODT for acute migraine relief in India, benefiting millions affected annually.

Drug maker Pfizer said on Monday that it has launched a new migraine medication in India. Introducing Rimegepant ODT for ...

Pfizer has agreed to acquire Metsera for $10 billion, outbidding Novo Nordisk in a heated competition. Metsera's board ...

NEW DELHI, Dec 6 (Reuters) - Pfizer Inc (PFE.N), opens new tab has applied for emergency use authorisation of its coronavirus vaccine in India, a top government health adviser said in a TV interview ...